Pancreatic cancer trials in Hungary
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Budapest
- Age
- 12 years and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - Phase 3Taking peopleAtebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Budapest VIII, Budapest XII, Debrecen, Kecskemét
- Age
- 18 years and over
- People
- 570 worldwide
- Run by
- Immuneering Corporation
See details and how to joinNCT07562152 · EU 2026-525617-31-00 - No phaseTaking peoplePancreatic Cancer Early Detection Consortium
- Where
- Budapest
- Age
- 18 years to 90 years
- People
- 20,000 worldwide
- Run by
- Arbor Research Collaborative for Health
See details and how to joinNCT04970056 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Kecskemét
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 3Taking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Budapest XII
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - Phase 1Taking peopleStudy to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
- Where
- Budapest XII
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Duke Street Bio Ltd
See details and how to joinNCT06458712 · EU 2023-508805-26-00 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Budapest XII, Tatabánya
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00